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Abstract
Background: Hand, foot and mouth disease (HFMD), a virus-induced infectious disease that usually affects infants
and children, has an increased incidence in China in recent years. This study attempted to investigate the role of
the Notch signaling pathway in the pathogenesis of HFMD.
Methods: Eighty-two children diagnosed with HFMD were enrolled into this study. The HFMD group was further
divided into the uncomplicated HFMD and HFMD with encephalitis groups. The control group included 40 children
who underwent elective surgery for treatment of inguinal hernias.
Results: Children with HFMD displayed significantly reduced CD3+, CD3+CD4+ and CD3+CD8+ cell subsets, but
substantially enhanced CD3−CD19+ cell subset (p < 0.05 versus control subjects). The expression levels of Notch
ligands Dll1 and Dll4 in the peripheral blood of the HFMD group were significantly higher than those in the control
group (p < 0.05). There were statistically significant differences in CD3+, CD3+CD4+ and CD3−CD19+ cell subsets, but not
in Notch ligand expression, between the uncomplicated HFMD and HFMD with encephalitis groups. Dll4 expression in
HFMD subjects correlated negatively with the CD3+ and CD3+CD8+ cell subsets (p < 0.05), but positively with the
CD3−CD19+ cell subset (p < 0.05). Furthermore, Dll4 expression in HFMD with encephalitis subjects correlated
positively with total white blood cell (WBC) counts and total protein contents in cerebrospinal fluid (CSF) (p < 0.05).
Conclusions: The Notch ligand Dll4 exhibits a strong correlation with the CD3+, CD3+CD8+ and CD3−CD19+ cell subsets
in children with HFMD, indicating that the Notch signaling may be involved in the development of HFMD by affecting
the number and status of peripheral lymphocytes.
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Background
Hand, foot and mouth disease (HFMD) is a common infec-
tious disease worldwide, which usually affects infants and
children. In recent years, HFMD has become increasingly
prevalent in the Asia-pacific region, particularly in China.
HFMD is contagious and can be lethal in infants and chil-
dren with severe cases. In China, there were 1,619,706
HFMD cases diagnosed with 509 deaths in 2011, 2,168,737
HFMD cases diagnosed with 567 deaths in 2012, and
1,828,377 HFMD cases diagnosed with 252 deaths in 2013,
respectively [1,2]. The major pathogens of HFMD in these
cases were enterovirus 71 (EV71) and coxsackie A virus
A16 (CoxA 16) [1,2], but the precise mechanism (s) for the
pathogenesis of HFMD has not yet been fully elucidated.
Previous studies reported that children with HFMD dis-
played substantial immune disorders [3,4].
Notch signaling can promote or suppress cell prolifer-
ation, cell death, acquisition of specific cell fates, or acti-
vation of differentiation programs in a context-dependent
manner, thus controlling cell fate and tissue homeostasis
[5]. It has been shown that the Notch signaling pathway
links both the innate immunity and the adaptive immunity,
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and affects the differentiation and development of T cells,
B cells and natural killer (NK) cells, thereby playing an im-
portant role in the activation of host immune system
against infectious disease [6-8]. Furthermore, Notch li-
gands Dll1 and Dll4 are both involved in the initiation of
an anti-viral response [9,10]. While type-I IFN-induced
Dll1 expression on macrophages plays a critical role in pre-
venting influenza A virus infection [9], Dll4 appears to limit
physiologic and pathologic changes in the lung during re-
spiratory syncytial virus infection by modulating the Th2
response [10]. However, it is unclear whether the Notch
signaling is involved in the pathogenesis of HFMD. To our
knowledge, there has been no previous work reported on
the role of the Notch signaling pathway in HFMD. In the
present study, we attempted to identify correlations be-
tween the Notch signaling pathway and the immune status
in pediatric patients with HFMD by assessing expression
levels of Notch ligands and subsets of lymphocytes in the
peripheral blood collected from children with HFMD. Our
findings suggest a possible role for the Notch signaling
pathway in HFMD.
Methods
Study population
A total of 82 pediatric patients who were admitted into
the infection ward and Pediatric Intensive Care Unit of
Affiliated Children’s Hospital, Soochow University, Suzhou,
China and diagnosed with HFMD between June 2012 and
December 2012 were recruited into this study. Among 82
cases, 42 cases with no complications were included in the
uncomplicated HFMD group and 40 cases with encephal-
itis were included in the HFMD with encephalitis group.
There were 26 males and 16 females in the uncomplicated
group with an average age of 2.23 years ranging from 0.33
to 7 years and 24 males and 16 females in the encephalitis
group with an average age of 2.6 years ranging from 0.75
to 9 years. The control group was comprised of 40 children
(35 males and 5 females) with average age of 5.33 years
ranging from 0.25 to 14 years who were scheduled for
elective surgery of inguinal hernia repair. This study was
approved by the Institutional Research Ethics Committee
of Affiliated Children’s Hospital and Soochow University
for clinical investigation, and the written informed consent
was obtained from all study participants and/or their par-
ents or guardians before enrollment. All experiments and
procedures followed were conducted in accordance with
the principles of the Declaration of Helsinki involving hu-
man subjects.
The diagnosis of HFMD and HFMD with encephalitis
was based on the WHO diagnostic criteria [11]. Symp-
toms in HFMD children include fever and rashes (maculo-
papule, papules and small herpes) located on the hands,
feet, mouth and buttocks, potentially accompanied by
coughing, runny nose and lack of appetite. HFMD children
complicated with encephalitis could display meningitis,
encephalitis, poliomyelitis-like syndrome and enceph-
alomyelitis symptoms and signs including weakness,
lethargy, hyperarousal, headache, vomiting, dysphoria,
shaky limbs, acute limb weakness and stiff neck, etc.
Analysis of cerebrospinal fluid (CSF) in children with
HFMD subjects revealed aseptic meningitis changes.
Pediatric Risk of Mortality III (PRISM III) [12] was used
to assess the disease severity in children with HFMD.
Real-time qPCR
Real-time quantitative RT-PCR (q-PCR) was used to de-
tect the expression levels of Notch ligands Dll1, Dll4,
Jagged1 and Jagged2 in the peripheral blood. Total RNA
was extracted using TRIzol (Invitrogen) and the single-
stranded cDNA was synthesized using M-MLV reverse
transcriptase (Invitrogen). Real-time qPCR was performed
with the SYBR Green PCR Mix on a LightCycler System
(Roche). The primers sequences used were hJAG1 sense-
5’-AATGGTTATCGCTGTATCTG-3’ and antisense-5’-TC
ACTGGCACGGTTGTAG-3’, hJAG2 sense-5’-AGTTCCA
GTGCGATGCCTACA-3’ and antisense-5’-GCTACAGCG
ATACCCGTTGAT-3’, hDLL1 sense-5’-GGGTCATCCTT
GTCCTCAT-3’ and antisense-5’-CTTGGTGTCACGCTT
GCT-3’, hDLL4 sense-5’-ACAGCCTATCTGTCTTTCGG-3’
and antisense-5’-GGCAGTGGTAGCCATCCT-3’ and glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH), sense-
5’-AAGCTCACTGGCATGGCCTT-3’ and antisense-5’-
CTCTCTTCCTCTTGTGCTCTT G-3’. The transcript
abundance was calculated using the ΔΔCt method, and
the mRNA expression level of each Notch ligand was the
ratio of normalized mean of GAPDH.
FACScan analysis
Heparinized blood samples collected from different groups
were dual- or triple-stained with anti-human CD3 (clone
UCHT1, Beckman Coulter, Fullerton, CA), anti-human
CD4 (clone SFCI12T4D11, Beckman Coulter), anti-human
CD8 (clone SFCI21Thy2D3, Beckman Coulter), anti-human
CD16 (clone 3G8, Beckman Coulter), anti-human CD19
(clone 89B, Beckman Coulter) and anti-human CD56
(clone N901, Beckman Coulter) mAbs conjugated with
phycoerythrin (PE), fluorescein isothiocyanate (FITC)
or phycoerythrin-Texas Red (ECD). PE-, FITC- or ECD-
conjugated anti-human isotype-matched mAbs (Beckman
Coulter) were used as negative controls. Erythrocytes
were lysed with OptiLyse C (Beckman Coulter). FACS-
can analysis was performed for at least 10,000 events
for detection of lymphocyte subsets in the peripheral
blood including CD3+, CD3+CD4+, CD3+CD8+, CD3−CD19+
and CD3−CD16+CD56+ cells on a Coulter FC500 flow
cytometer (Beckman Coulter) equipped with EXPO32
software (Beckman Coulter).
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Total WBC counting and protein measurement in CSF
CSF samples were collected from subjects in HFMD
with encephalitis group. A 100 μl CSF sample was used
to determine total WBC counts using a haemacytometer.
Total protein contents in CSF samples were assessed by
micro pyrogallol red colorimetric method.
Statistical analysis
Results are expressed as mean ± standard deviation (SD).
Data were collected and analyzed using GraphPad soft-
ware, version 5.01 (Prism, La Jolla, CA). All data were
tested for normal distribution and homogeneity of vari-
ance. The unpaired student’s t-test was used to compare
the means between two groups. The unpaired student’s
t-test with Welch’s correction was used to analyze non-
normally distributed values. The Spearman rank correl-
ation coefficient test was used to assess correlations
between Notch ligand expression and lymphocyte sub-
sets in the peripheral blood. A p-value of less than 0.05
was considered to be statistically significant.
Results
Alterations in peripheral lymphocyte subsets in HFMD
subjects
The numbers of CD3+ (p = 0.014), CD3+CD4+ (p = 0.006)
and CD3+CD8+ (p = 0.001) cells in the peripheral blood of
the HFMD group were significantly lower than those in
the control group, whereas the number of CD3−CD19+
cells (p = 0.007) in the peripheral blood of the HFMD
group was significantly higher than that in the control
group (Table 1). No significant difference in the number
of peripheral CD3−CD16+CD56+ cells was found between
the HFMD and control groups (Table 1). The numbers
of peripheral CD3+ (p = 0.023) and CD3+CD4+ (p = 0.039)
cells in the uncomplicated HFMD group were substan-
tially higher than those in the HFMD with encephalitis
group, whereas the number of peripheral CD3−CD19+
cells (p = 0.001) was significantly lower in the uncompli-
cated HFMD group compared to the HFMD with en-
cephalitis group (Table 2). There were no significant
differences in the numbers of peripheral CD3+CD8+
and CD3−CD16+CD56+ cells found between the uncom-
plicated HFMD and HFMD with encephalitis groups
(Table 2).
Levels of Notch ligand expression between HFMD and
control subjects
The expression levels of Notch ligands Dll1 (p = 0.000)
and Dll4 (p = 0.002) in the peripheral blood of the
HFMD group were significantly higher than those of the
control group (Figure 1); however, there were no signifi-
cant differences in Jagged1 and Jagged2 expression levels
found between the HFMD and control groups (Figure 1).
There were also no significant differences in Dll1, Dll4,
Jagged1 and Jagged2 expression levels found between
the uncomplicated HFMD and HFMD with encephalitis
groups (Figure 2).
Correlations between Dll4 expression and peripheral
lymphocyte subsets
The expression levels of Notch ligand Dll4 in the peripheral
blood of the HFMD group correlated negatively with the
numbers of peripheral CD3+ (R-square = −0.299, p = 0.004)
and CD3+CD8+ (R-square = −0.234, p = 0.025) lymphocytes,
but correlated positively with the number of peripheral
CD3−CD19+ lymphocyte (R-square = 0.364, p = 0.000)
(Figure 3). There were no correlations found between
Dll4 levels and peripheral CD3+CD4+ (R-square = −0.098,
p = 0.351) and CD3−CD16+CD56+ (R-square = 0.020, p =
0.853) cell counts (Figure 3). By contrast, the expression
levels of Dll1 did not correlated with the numbers of per-
ipheral lymphocyte subsets (data not shown).
Association between Dll4 expression levels and HFMD
A positive correlation was found in the HFMD with en-
cephalitis group between Dll4 expression levels in the
peripheral blood and total WBC counts in CSF (R-square =
0.445, p = 0.005) as well as between Dll4 expression
levels in the peripheral blood and total protein contents
in CSF (R-square = 0.372, p = 0.012) (Figure 4). How-
ever, the expression levels of Dll4 in the peripheral
blood of HFMD subjects did not correlate significantly
Table 1 Comparison of lymphocyte subsets in the
peripheral blood between the control group (n = 40) and
the HFMD group (n = 82)
Lymphocyte subsets (%) Control HFMD p values
CD3+ 59.94 ± 6.41 56.52 ± 9.83 0.014
CD3+CD4+ 32.15 ± 6.31 28.57 ± 8.36 0.006
CD3+CD8+ 26.42 ± 5.65 22.70 ± 6.59 0.001
CD3−CD19+ 21.41 ± 6.38 24.93 ± 8.50 0.007
CD3−CD16+CD56+ 17.08 ± 5.99 15.82 ± 8.10 0.306
Data are mean ± SD. Statistical significance was evaluated by unpaired
student’s t-test.
Table 2 Comparison of lymphocyte subsets in the
peripheral blood between the uncomplicated HFMD
group (n = 42) and the HFMD with encephalitis group
(n = 40)
Lymphocyte subsets (%) Uncomplicated Encephalitis p values
CD3+ 58.42 ± 8.99 54.21 ± 10.40 0.023
CD3+CD4+ 30.04 ± 8.87 26.79 ± 7.40 0.039
CD3+CD8+ 23.14 ± 6.42 22.00 ± 6.88 0.443
CD3−CD19+ 22.62 ± 7.87 27.74 ± 8.46 0.001
CD3−CD16+CD56+ 16.40 ± 7.38 15.13 ± 8.92 0.412
Data are mean ± SD. Statistical significance was evaluated by unpaired
student’s t-test.
Bai et al. BMC Infectious Diseases 2014, 14:337 Page 3 of 7
http://www.biomedcentral.com/1471-2334/14/337
with the duration of fever, length of hospital stay, the
biochemical markers CRP, Glu, Alt, Ast, CK and CK-
MB, and the PRISM III score (data not shown).
Discussion
HFMD is a virus-induced infectious disease, which can
lead to serious consequences especially in infants and chil-
dren. Several studies have shown that children with HFMD
undergo significant alterations in their immune status
[3,4]. However, the precise mechanism (s) responsible for
altered immune functions in patients with HFMD has not
yet been fully clarified.
In the present study, we found that children with HFMD
displayed significant decreases in their peripheral CD3+,
CD3+CD4+ and CD3+CD8+ cell subsets, but had a sub-
stantial increase in their peripheral CD3−CD19+ cell subset.
Moreover, children in the HFMD with encephalitis group
showed further reduction in the CD3+ and CD3+CD4+ cell
subsets and elevation in the CD3−CD19+ cell subset com-
pared to children in the uncomplicated HFMD group.
Figure 1 Comparison of the expression levels of Notch ligands Dll1, Dll4, Jagged1 and Jagged2 in the peripheral blood between the
control group (n = 40) and the HFMD group (n = 82). The mRNA expression levels of Dll1, Dll4, Jagged1 and Jagged2 were assessed by real-time
q-PCR and normalized with GAPDH as described in the Methods. Each dot represents individual case and the horizontal line represents the mean.
Statistical significance was evaluated by unpaired student’s t-test with Welch’s correction.
Figure 2 Comparison of the expression levels of Notch ligands Dll1, Dll4, Jagged1 and Jagged2 in the peripheral blood between the
uncomplicated HFMD group (n = 42) and the HFMD with encephalitis group (n = 40). The mRNA expression levels of Dll1, Dll4, Jagged1
and Jagged2 were assessed by real-time q-PCR and normalized with GAPDH as described in the Methods. Each dot represents individual case
and the horizontal line represents the mean. Statistical significance was evaluated by unpaired student’s t-test with Welch’s correction.
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These results are consistent with previously reported find-
ings in the mainland of China and Taiwan [3,4]. We also
found significant increases in the expression levels of
Notch ligands Dll1 and Dll4 in the peripheral blood of
children with HFMD, suggesting that Notch signaling
might be initiated and activated during HFMD via the en-
gagement of upregulated Notch ligand Dll1 or Dll4 with
Notch receptors, which subsequently affects the differenti-
ation and development of T and B lymphocytes.
It is unclear whether the Notch signaling is associated
with changes in the immune status observed in children
with HFMD. Previous studies have shown that the Notch
signaling pathway possesses a crucial role in differentiations
of a variety of immune cells [13,14]. Mukuherjee et al. [15]
Figure 3 Correlation between the Dll4 expression levels and the CD3+, CD3+CD4+, CD3+CD8+, CD3−CD19+, or CD3−CD16 + CD56+ cell
subsets in HFMD patients (n = 82). Dll4 mRNA expression and lymphocyte subsets were assessed by real-time q-PCR and FACScan analysis
respectively, as described in the Methods. Each dot represents individual case and each line indicates the best-fit line. R2 values were calculated
by Spearman rank correlation coefficient test.
Figure 4 Association between the Dll4 expression levels and CSF WBC counts or CSF protein contents in HFMD patients with encephalitis
(n = 40). Dll4 mRNA expression was assessed by real-time q-PCR. CSF WBC counts and protein contents were determined as described in the Methods.
Each dot represents individual case and each line indicates the best-fit line. R2 values were calculated by Spearman rank correlation coefficient test.
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found that the Notch ligand Dll4 promoted T-cell dif-
ferentiation through increased expression of IL-17 and
RORγ T. Schaller et al. [10] also found that Dll4 ex-
pression on bone marrow-derived dendritic cells (DCs)
increased significantly after infection of mice with re-
spiratory syncytial virus, accompanied by increased se-
cretion of Th2 cytokines and reduced production of
INF-γ. In the present study, we performed a correlation
analysis of the cell counts of different lymphocyte sub-
sets with Notch ligand expression levels in the peripheral
blood of children with HFMD. Our data demonstrated
that peripheral lymphocyte subsets had statistically signifi-
cant correlations with the Notch ligand Dll4 expression.
The Dll4 expression levels showed negative correlations
with CD3+ and CD3+CD8+ cell subsets, but a positive
correlation with CD3−CD19+ cell subset that has the B
lymphocyte surface antigen characteristics, suggesting that
the up-regulated Dll4 expression may be associated with a
relatively inhibited status of CD3+ lymphocytes and a rela-
tively activated status of CD3−CD19+ lymphocytes ob-
served in children with HFMD. It has been reported that
the prognosis of sepsis correlates closely with the numbers
of NK cells, CD3+, CD3+CD4+ and CD3+CD8+ lympho-
cytes [16]. Therefore, it is possible that the Notch signal-
ing pathway also affects HFMD prognosis by interfering
with the number and status of these immune cells.
In the present study, we further showed that the Dll4
expression levels in the peripheral blood correlated posi-
tively with total WBC counts and total protein contents
in CSF, but there were no correlations of the Dll4 ex-
pression levels with the duration of fever, length of hos-
pital stay, the biochemical markers CRP, Glu, Alt, Ast,
CK and CK-MB, and the PRISM III score. The total
WBC counts and total protein contents in CSF are crit-
ical for the diagnosis of encephalitis and are also indica-
tors for the degree of brain inflammation [17,18].
However, we did not observe any significant differences
in Notch ligand expression such as the Dll4 level be-
tween the uncomplicated HFMD group and the HFMD
with encephalitis group. Further work is needed to verify
whether Dll4 can be used as a clinical indicator for de-
termination of the severity of HFMD.
A crucial cause of death in children with severe
HFMD is the neurogenic pulmonary edema. Infection
with EV71 generates viremia or penetrates directly into
the central nervous system where it mainly affects the
brainstem, which leads to disorders of the autonomic
nerve function and stimulation of sympathetic nerve sys-
tem [19-22]. The over-activated sympathetic nerve sys-
tem causes a massive release of catecholamines [23],
resulting in systemic vasoconstriction and a shift of
blood flow from the systemic circulation to the pulmon-
ary circulation, which finally leads to the development of
neurogenic pulmonary edema. It has been reported that
activation of angiopoietin 2 and Dll4 can promote regen-
eration of the damaged dopamine neurons, thereby result-
ing in catecholamine such as dopamine release [24].
Children with severe HFMD may also release significant
amounts of catecholamine. In the present study, we fur-
ther observed substantially up-regulated Notch ligand
Dll4 (or activation of Dll4) in children with HFMD. Thus,
our further work will examine whether pharmacological
inhibition of Dll4 could attenuate catecholamine release,
thereby reducing the incidence of neurogenic pulmonary
edema in children with severe HFMD.
Conclusions
Children with HFMD undergo significant changes in
their immune status, and the Notch signaling pathway
may play an important role in these changes. Further-
more, the Notch ligand Dll4 correlates strongly with the
peripheral CD3+, CD3+CD8+ and CD3−CD19+ lympho-
cyte subsets, indicating that Dll4 may participate in the
pathogenesis of HFMD by interfering with the number
and status of these immune cells.
Abbreviations
CoxA 16: Coxsackie A virus A16; CSF: Cerebrospinal fluid; DCs: Dendritic cells;
ECD: phycoerythrin-texas red; EV71: Enterovirus 71; FITC: Fluorescein
isothiocyanate; HFMD: Hand, foot and mouth disease; NK cells: Natural killer
cells; PE: Phycoerythrin; PRISM III: Pediatric risk of mortality III; q-PCR: quantitative
RT-PCR; WBC: White blood cells.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ZJB, YPL, JHW, JW conceived and designed the experiments. ZJB, YPL, JH,
YJX, CYL performed the experiments. ZJB, YPL, XXK, JMT, JHW, JW analyzed
the data. ZJB, YPL, JHW, JW wrote the paper. All authors read and approved
the final manuscript.
Acknowledgements
This work was supported by the National Natural Science Foundation of China
(Grant 81272143), the National Natural Science Foundation of Jiangsu Province
(Grant BK2011310), Jiangsu Innovation Team (Grant LJ201141), Jiangsu Province
Program of Innovative and Entrepreneurial Talents (2011–2014).
Author details
1Pediatric Intensive Care Unit, Affiliated Children's Hospital, Soochow
University, Suzhou, China. 2Institute of Pediatric Research, Affiliated Children's
Hospital, Soochow University, Suzhou, China. 3Department of Pediatric
Surgery, Affiliated Children's Hospital, Soochow University, Suzhou, China.
4Department of the Infectious Disease, Affiliated Children’s Hospital,
Soochow University, Suzhou, China. 5Department of Academic Surgery,
University College Cork, Cork University Hospital, Cork, Ireland.
Received: 30 August 2013 Accepted: 12 June 2014
Published: 17 June 2014
References
1. CDC. [http://www.moh.gov.cn/mohjbyfkzj/s3578/201202/54106.shtml]
[www.moh.gov.cn/jkj/…/26700e8a83c04205913a106545069a11.shtml]
2. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ,
Zheng Y, Cowling BJ, Varma JK, Farrar JJ, Leung GM, Yu H: Hand, foot, and
mouth disease in China, 2008–12: an epidemiological study. Lancet Infect
Dis 2014, 14:308–318.
Bai et al. BMC Infectious Diseases 2014, 14:337 Page 6 of 7
http://www.biomedcentral.com/1471-2334/14/337
3. Fu D, Li CR, He YX, Zu Y, Cao DZ, Wang GB, Deng JK, Wang HP: Changes of
immune function in patients with enterovirus 71 infection. Zhonghua Er
Ke Za Zhi 2009, 47:829–834.
4. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC:
Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric
patients: roles of cytokines and cellular immune activation in patients
with pulmonary edema. J Infect Dis 2003, 188:564–570.
5. Kopan R, Ilagan MX: The canonical Notch signaling pathway: unfolding
the activation mechanism. Cell 2009, 137:216–233.
6. Lukacs NW, Smit JJ, Schaller MA, Lindell DM: Regulation of immunity to
respiratory syncytial virus by dendritic cells, toll-like receptors, and
notch. Viral Immunol 2008, 21:115–122.
7. Ito T, Connet JM, Kunkel SL, Matsukawa A: Notch system in the linkage of
innate and adaptive immunity. J Leukoc Biol 2012, 92:59–65.
8. Andersson ER, Sandberg R, Lendahl U: Notch signaling: simplicity in
design, versatility in function. Development 2011, 138:3593–3612.
9. Ito T, Allen RM, Carson WF 4th, Schaller M, Cavassani KA, Hogaboam CM,
Lukacs NW, Matsukawa A, Kunkel SL: The critical role of Notch ligand
Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection.
PLoS Pathog 2011, 7:e1002341.
10. Schaller MA, Neupane R, Rudd BD, Kunkel SL, Kallal LE, Lincoln P, Lowe JB,
Man Y, Lukacs NW: Notch ligand Delta-like 4 regulates disease pathogenesis
during respiratory viral infections by modulating Th2 cytokines. J Exp Med
2007, 204:2925–2934.
11. WHO: A guide to clinical management and public health response for
hand, foot and mouth disease (HFMD). [http://www.wpro.who.int/
publications/docs/GuidancefortheclinicalmanagementofHFMD.pdf]
12. Pollack MM, Patel KM, Ruttimann UE: PRISM III: an updated pediatric risk
of mortality score. Crit Care Med 1996, 24:743–752.
13. Van de Walle I, De Smet G, De Smedt M, Vandekerckhove B, Leclercq G,
Plum J, Taghon T: An early decrease in Notch activation is required for
human TCR-alphabeta lineage differentiation at the expense of TCR-
gammadelta T cells. Blood 2009, 113:2988–2998.
14. Amsen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M,
McCright B, Gridley T, Flavell RA: Direct regulation of Gata 3 expression
determines the T helper differentiation potential of Notch. Immunity
2007, 27:89–99.
15. Mukuherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW: Regulation
of T cell activation by Notch ligand, DLL4, promotes IL-17 production
and Rorc activation. J Immunol 2009, 182:7381–7388.
16. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandía F, Loma
AM, Nieto C, Diego R, Ramos E, Nocito M, Resino S, Eiros JM, Tamayo E, de
Lejarazu RO, Bermejo-Martin JF: Early natural killer cell counts in blood
predict mortality in severe sepsis. Crit Care 2011, 15:R243.
17. Kim SJ, Kim JH, Kang JH, Kim DS, Kim KH, Kim KH, Kim YH, Chung JY, Bin JH,
Jung Da E, Kim JH, Kim HM, Cheon DS, Kang BH, Seo SY: Enteroviruses
Complications Working Group: Risk factors for neurologic complications
of hand, foot and mouth disease in the Republic of Korea, 2009. J Korean
Med Sci 2013, 28:120–127.
18. Cho HK, Lee NY, Lee H, Kim HS, Seo JW, Hong YM, Lee SJ, Lee SW, Cheon
DS, Hong JY, Kang BH, Kim JH, Kim KH: Enterovirus 71-associated hand,
foot and mouth diseases with neurologic symptoms, a university
hospital experience in Korea, 2009. Korean J Pediatr 2010, 53:639–643.
19. Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, Yang YJ, Lin SJ,
Yeh TF: Clinical spectrum of enterovirus 71 infection in children in
southern Taiwan, with an emphasis on neurological complications.
Clin Infect Dis 1999, 29:184–190.
20. Kao SJ, Yang FL, Hsu YH, Chen HI: Mechanism of fulminant pulmonary
edema caused by enterovirus 71. Clin Infect Dis 2004, 38:1784–1788.
21. Zeng H, Wen F, Gan Y, Huang W: MRI and associated clinical
characteristics of EV71-induced brainstem encephalitis in children with
hand-foot-mouth disease. Neuroradiology 2012, 54:623–630.
22. Zheng XQ, Chen XQ, Gao Y, Fu M, Chen YP, Xu DP, Lin A, Yan WH: Elevation
of human leukocyte antigen-G expression is associated with the severe
encephalitis associated with neurogenic pulmonary edema caused by
enterovirus 71. Clin Exp Med 2013. April 21. [Epub ahead of print].
23. Inamasu J, Sugimoto K, Yamada Y, Ganaha T, Ito K, Watabe T, Hayashi T,
Kato Y, Ozaki Y, Hirose Y: The role of catecholamines in the pathogenesis
of neurogenic pulmonary edema associated with subarachnoid
hemorrhage. Acta Neurochir 2012, 154:2179–2184.
24. Androutsellis-Theotokis A, Rueger MA, Park DM, Mkhikian H, Korb E, Poser
SW, Walbridge S, Munasinghe J, Koretsky AP, Lonser RR, McKay RD:
Targeting neural precursors in the adult brain rescues injured dopamine
neurons. Proc NatI Acad Sci USA 2009, 106:13570–13575.
doi:10.1186/1471-2334-14-337
Cite this article as: Bai et al.: The significance of Notch ligand expression
in the peripheral blood of children with hand, foot and mouth disease
(HFMD). BMC Infectious Diseases 2014 14:337.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bai et al. BMC Infectious Diseases 2014, 14:337 Page 7 of 7
http://www.biomedcentral.com/1471-2334/14/337
